newsfilter
← Latest News
GlobeNewswire·

Journey Medical Corporation to Announce First Quarter 2026 Financial Results on May 13, 2026

  • Journey Medical Corporation (NASDAQ: DERM) will release its first quarter 2026 financial results after U.S. markets close on Wednesday, May 13, 2026.
  • Management will host a conference call & audio webcast on Wednesday, May 13, 2026 at 4:30 p.m. ET.
  • Domestic callers should dial 1-866-777-2509; international callers should dial 1-412-317-5413.
  • Participants must register at https://dpregister.com/sreg/10209171/10401b25258 to receive dial-in numbers.
  • A live audio webcast will be available on the Investors section of www.journeymedicalcorp.com for replay for approximately 30 days.
  • Journey Medical is a commercial-stage pharmaceutical company focusing on FDA-approved prescription drugs for dermatological conditions.
  • The Company currently markets eight branded FDA-approved prescription drugs.
  • The Company is located in Scottsdale, Arizona, was founded by Fortress Biotech, Inc., & files reports with the SEC.